News Monitor

Marketing Tools

New Compliance Program Puts Hepatitis Patients 'In Charge'

Schering Oncology/Biotech (Kenilworth, N.J.) is targeting chronic hepatitis B and C patients on its Intron A prescription drug therapy with a new compliance/comprehensive program called "Be In Charge," launched earlier this month.